AF
KNSA icon

Allworth Financial’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Allworth Financial’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29K Buy
453
+134
+42% +$6.95K ﹤0.01% 2902
2026
Q1 		$15.4K Buy
319
+190
+147% +$8.42K ﹤0.01% 3182
2025
Q4 		$5.32K Buy
129
+23
+22% +$923 ﹤0.01% 3663
2025
Q3 		$4.12K Buy
106
+42
+66% +$1.36K ﹤0.01% 3663
2025
Q2 		$1.77K Buy
+64
New +$1.63K ﹤0.01% 3762
2023
Q3 		– Sell
-23
Closed -$324 – 3490
2023
Q2 		$324 Buy
+23
New +$308 ﹤0.01% 2994

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Allworth Financial's KNSA Position: Q2 2026 in Review

Allworth Financial increased its Kiniksa Pharmaceuticals (KNSA) stake by 42% in Q2 2026, buying an estimated $6.95K and bringing the position to 453 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #2902.

Allworth Financial first reported a position in KNSA in Q2 2023 and has held it in 6 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Allworth Financial held 453 shares of Kiniksa Pharmaceuticals worth $29K as of Q2 2026.
  • Allworth Financial bought 134 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $6.95K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2902 holding.
  • Allworth Financial first reported a position in Kiniksa Pharmaceuticals in Q2 2023 and has held it in 6 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.